相似文献
1
Analysis of clarithromycin resistance and CagA status in Helicobacter pylori by use of feces from children in Thailand.
J Clin Microbiol. 2009 Dec;47(12):4144-5. doi: 10.1128/JCM.00786-09. Epub 2009 Sep 30.
2
High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children.
J Clin Microbiol. 2010 Nov;48(11):4266-8. doi: 10.1128/JCM.01034-10. Epub 2010 Sep 8.
3
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.
Microb Pathog. 2018 Oct;123:330-338. doi: 10.1016/j.micpath.2018.07.016. Epub 2018 Jul 18.
4
Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis.
Infect Genet Evol. 2016 Oct;44:190-198. doi: 10.1016/j.meegid.2016.06.044. Epub 2016 Jun 26.
5
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Rev Esp Quimioter. 2006 Mar;19(1):34-8.
6
Can bacterial virulence factors predict antibiotic resistant infection?
World J Gastroenterol. 2018 Mar 7;24(9):971-981. doi: 10.3748/wjg.v24.i9.971.
7
Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction.
Helicobacter. 2018 Feb;23(1). doi: 10.1111/hel.12450. Epub 2017 Nov 27.
8
Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12396. Epub 2017 May 22.
9
Claritromycin resistance and Helicobacter pylori genotypes in Italy.
J Microbiol. 2006 Dec;44(6):660-4.
10
Polymerase chain reaction--restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample.
Helicobacter. 2005 Jun;10(3):205-13. doi: 10.1111/j.1523-5378.2005.00312.x.
引用本文的文献
1
virulence genes of minor ethnic groups in North Thailand.
Gut Pathog. 2017 Oct 11;9:56. doi: 10.1186/s13099-017-0205-x. eCollection 2017.
2
Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication.
Asian Pac J Cancer Prev. 2017 Apr 1;18(4):927-932. doi: 10.22034/APJCP.2017.18.4.927.
3
Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.
World J Methodol. 2015 Sep 26;5(3):164-74. doi: 10.5662/wjm.v5.i3.164.
4
Evaluation of Helicobacter pylori vacA and cagA Genotypes and Correlation With Clinical Outcome in Patients With Dyspepsia in Hamadan Province, Iran.
Iran Red Crescent Med J. 2014 Nov 5;16(11):e19173. doi: 10.5812/ircmj.19173. eCollection 2014 Nov.
5
Five year monitoring of considerable changes in tyrosine phosphorylation motifs of Helicobacter pylori cagA gene in Iran.
J Appl Genet. 2015 Feb;56(1):149-50. doi: 10.1007/s13353-014-0249-2. Epub 2014 Oct 9.
6
Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes.
Gut Pathog. 2014 Jun 26;6:27. doi: 10.1186/1757-4749-6-27. eCollection 2014.
7
Five-year monitoring of considerable changes in tyrosine phosphorylation motifs of the Helicobacter pylori cagA gene in Iran.
J Appl Genet. 2014 Aug;55(3):417-22. doi: 10.1007/s13353-014-0209-x. Epub 2014 Apr 26.
8
Non-invasive genotyping of Helicobacter pylori cagA, vacA, and hopQ from asymptomatic children.
Helicobacter. 2012 Apr;17(2):96-106. doi: 10.1111/j.1523-5378.2011.00919.x.
9
High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain.
J Clin Microbiol. 2010 Oct;48(10):3703-7. doi: 10.1128/JCM.00144-10. Epub 2010 Jul 28.
本文引用的文献
1
Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces.
J Med Microbiol. 2007 Sep;56(Pt 9):1174-1180. doi: 10.1099/jmm.0.47302-0.
2
Efficacy of clarithromycin-based triple therapy for treating Helicobacter pylori in Thai non-ulcer dyspeptic patients with clarithromycin-resistant strains.
J Med Assoc Thai. 2006 Sep;89 Suppl 3:S74-8.
3
Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan.
Int J Antimicrob Agents. 2007 Sep;30(3):250-4. doi: 10.1016/j.ijantimicag.2007.04.009. Epub 2007 Jun 21.
4
Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma.
World J Gastroenterol. 2006 Mar 7;12(9):1346-51. doi: 10.3748/wjg.v12.i9.1346.
5
Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR.
J Clin Microbiol. 2005 Feb;43(2):791-5. doi: 10.1128/JCM.43.2.791-795.2005.
6
Tyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells.
J Clin Microbiol. 2005 Feb;43(2):786-90. doi: 10.1128/JCM.43.2.786-790.2005.
7
Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer.
J Infect Dis. 2004 Mar 1;189(5):820-7. doi: 10.1086/381782. Epub 2004 Feb 2.
8
Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14428-33. doi: 10.1073/pnas.222375399. Epub 2002 Oct 21.
9
Helicobacter pylori and gastrointestinal tract adenocarcinomas.
Nat Rev Cancer. 2002 Jan;2(1):28-37. doi: 10.1038/nrc703.
10
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.
Antimicrob Agents Chemother. 1997 Dec;41(12):2621-8. doi: 10.1128/AAC.41.12.2621.
Zotero 插件